Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial.
Amarjeet TankS Claiborne JohnstonRitika JainPierre AmarencoCarl MellströmKlas RiknerHans DenisonPer LadenvallMikael KnutssonAnders HimmelmannScott R EvansStefan JamesCarlos A MolinaYongjun WangMario OuwensPublished in: BMJ neurology open (2023)
NCT03354429.
Keyphrases
- antiplatelet therapy
- low dose
- acute coronary syndrome
- percutaneous coronary intervention
- cardiovascular events
- liver failure
- study protocol
- respiratory failure
- phase iii
- clinical trial
- phase ii
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- aortic dissection
- type diabetes
- randomized controlled trial
- hepatitis b virus
- intensive care unit
- open label
- atrial fibrillation
- extracorporeal membrane oxygenation
- mechanical ventilation